BIODESIX INC
NASDAQ: BDSX (Biodesix, Inc.)
Kemas kini terakhir: 8 jam lalu8.53
-11.31 (-57.01%)
| Penutupan Terdahulu | 19.84 |
| Jumlah Dagangan | 1,581,376 |
| Harga / Jualan (P/S) | 1.85 |
| Harga / Buku (P/B) | 24.72 |
| Julat 52 Minggu |
| Margin Keuntungan | -54.28% |
| Margin Operasi (TTM) | -50.47% |
| EPS Cair (TTM) | -0.270 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 21.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 577.44% |
| Nisbah Semasa (MRQ) | 2.22 |
| Aliran Tunai Operasi (OCF TTM) | -41.94 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -31.89 M |
| Pulangan Atas Aset (ROA TTM) | -23.33% |
| Pulangan Atas Ekuiti (ROE TTM) | -1,454.41% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Diagnostics & Research (US) | Bercampur | Menaik |
| Diagnostics & Research (Global) | Bercampur | Menaik | |
| Stok | Biodesix, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Nilai 40% | -2.9 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | -2.9 |
| Masa 40% | -0.3 |
| AI Technical info | NA |
| Osilator Teknikal info | -0.5 |
| Purata Bergerak Teknikal info | 0.0 |
| Wang Pintar 20% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Persekitaran | ×1.21 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -17.7% |
| Persetujuan Tonggak | ×1.25 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | 0.9 |
| Skor Akhir | -1.94 |
|
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. |
|
| Sektor | Healthcare |
| Industri | Diagnostics & Research |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 52.11% |
| % Dimiliki oleh Institusi | 36.46% |
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |